t
| Date | 29 Nov 2023 |
| Time | 15:23:02 |
| Category | Holding(s) in company |
| ID | 1069V |
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BN7SWP63
Issuer Name
GSK PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
GSK plc
City of registered office (if applicable)
BRENTFORD
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
23-Nov-2023
6. Date on which Issuer notified
23-Nov-2023
7. Total positions of person(s) subject to the notification obligation
|
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|
|
Resulting situation on the date on which threshold was crossed or reached |
4.812370 |
0.000000 |
4.812370 |
197068169 |
|
Position of previous notification (if applicable) |
|
|
|
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
|
Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
|
GB00BN7SWP63 |
197068169 |
|
4.812370 |
|
|
Sub Total 8.A |
197068169 |
4.812370% |
||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
|
|
Sub Total 8.B1 |
|
|
|
|
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
|
|
|
|
|
|
|
|
Sub Total 8.B2 |
|
|
|
||
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
|
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
|
|
|
|
|
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
The notification relates to the transfer at market value of 20.0 million treasury shares held by GSK plc to GSK plc's UK Employee Share Ownership Trust required to meet the expected requirement arising from awards made under GSK plc's Long Term Incentive Plan until 2026 vestings.
Please note, the total amount of voting rights has been rounded to 6 decimal places therefore there is a possibility of a rounding error.
12. Date of Completion
29-Nov-2023
13. Place Of Completion
London